RTW Investments’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

RTW Investments’s Portfolio RCKTW Stock Details RCKTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.21K	Hold	350,000	–	–	﹤0.01%	88
2025 Q4	$8.51K	Hold	350,000	–	–	﹤0.01%	91
2025 Q3	$13.7K	Hold	350,000	–	–	﹤0.01%	74
2025 Q2	$10.1K	Hold	350,000	–	–	﹤0.01%	73
2025 Q1	$16.4K	Hold	350,000	–	–	﹤0.01%	68
2024 Q4	$12K	Hold	350,000	–	–	﹤0.01%	72
2024 Q3	$22.6K	Hold	350,000	–	–	﹤0.01%	68
2024 Q2	$21.2K	Hold	350,000	–	–	﹤0.01%	68
2024 Q1	$105K	Hold	350,000	–	–	﹤0.01%	69
2023 Q4	$172K	Hold	350,000	–	–	﹤0.01%	63
2023 Q3	$59.5K	Hold	350,000	–	–	﹤0.01%	67
2023 Q2	$66.5K	Hold	350,000	–	–	﹤0.01%	62
2023 Q1	$38.5K	Buy	+350,000	New	+$67.5K	﹤0.01%	60

Other funds holding RCKTW

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Walleye Capital

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return